Concepedia

Camilla Mollatt

CM

6

Publications

308

Citations

6

H-Index

2008

Active since

Affiliations

Nordic Nanovector (Norway)(Current)

Oslo University Hospital

Norwegian Cancer Society

Camilla Mollatt is an author at Nordic Nanovector (Norway) specializing in immunotherapy, pathology, and tumor microenvironment.

Top concepts

Publications per year

2008–2013

6

Publications

6

Tumor Vascularity Assessed By Magnetic Resonance Imaging and Intravital Microscopy Imaging

Jon-Vidar Gaustad, Kjetil Gundro Brurberg, Trude G. Simonsen et al. · Neoplasia · 2008 · 78 citations · Full text

Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumab

Helèn Heyerdahl, Nasir Abbas, Ellen Mengshoel Brevik et al. · PLoS ONE · 2012 · 60 citations · Full text

Temporal Heterogeneity in Blood Supply in Human Tumor Xenografts

Kjetil Gundro Brurberg, Jon‐Vidar Gaustad, Camilla Mollatt et al. · Neoplasia · 2008 · 45 citations · Full text

Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma.

Jostein Dahle, Ada H. V. Repetto‐Llamazares, Camilla Mollatt et al. · PubMed · 2013 · 45 citations

, , +16

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Ada H. V. Repetto‐Llamazares, Roy H. Larsen, Camilla Mollatt et al. · Current Radiopharmaceuticals · 2013 · 45 citations · Full text

Rows per page

1–5 of 6